Top Midday Decliners

MT Newswires Live03-27

Wave Life Sciences (WVE) said Thursday phase 1 data showed a 240-milligram dose of its WVE-007 improved body composition, with clinically meaningful reductions in visceral fat and waist circumference, at a six-month follow-up.

The company also reported data from participants in the 400 mg cohort, including visceral fat and total fat.

Shares sank 49%, with intraday trading volume of over 40 million shares, against a daily average of about 3.3 million.

Cibus (CBUS) said Thursday it has priced an underwritten public offering of almost 7 million class A shares at $2.15 apiece. The stock closed at $2.87 in the previous day.

Shares slid about 25% as intraday trading volume soared to over 1.66 million from a daily average of about 478,000.

Price: 6.43, Change: -5.87, Percent Change: -47.72

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2622893585?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 02:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622893585","market":"us","top_or_hot":-1,"title":"Top Midday Decliners","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/WVE\">Wave Life</a> Sciences (WVE) said Thursday phase 1 data showed a 240-milligram dose of its WVE-007 improved body composition, with clinically meaningful reductions in visceral fat and waist circumference, at a six-month follow-up.</p><p>The company also reported data from participants in the 400 mg cohort, including visceral fat and total fat.</p><p>Shares sank 49%, with intraday trading volume of over 40 million shares, against a daily average of about 3.3 million.</p><p>Cibus (CBUS) said Thursday it has priced an underwritten public offering of almost 7 million class A shares at $2.15 apiece. The stock closed at $2.87 in the previous day.</p><p>Shares slid about 25% as intraday trading volume soared to over 1.66 million from a daily average of about 478,000.</p><p>Price: 6.43, Change: -5.87, Percent Change: -47.72</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-27 02:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/WVE\">Wave Life</a> Sciences (WVE) said Thursday phase 1 data showed a 240-milligram dose of its WVE-007 improved body composition, with clinically meaningful reductions in visceral fat and waist circumference, at a six-month follow-up.</p><p>The company also reported data from participants in the 400 mg cohort, including visceral fat and total fat.</p><p>Shares sank 49%, with intraday trading volume of over 40 million shares, against a daily average of about 3.3 million.</p><p>Cibus (CBUS) said Thursday it has priced an underwritten public offering of almost 7 million class A shares at $2.15 apiece. The stock closed at $2.87 in the previous day.</p><p>Shares slid about 25% as intraday trading volume soared to over 1.66 million from a daily average of about 478,000.</p><p>Price: 6.43, Change: -5.87, Percent Change: -47.72</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"WVE","symbol_name":"Wave Life Sciences Pte. Ltd","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2622893585","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622893585","pubTimestamp":1774550199,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Wave Life Sciences  said Thursday phase 1 data showed a 240-milligram dose of its WVE-007 improved body composition, with clinically meaningful reductions in visceral fat and waist circumference, at a six-month follow-up.The company also reported data from participants in the 400 mg cohort, including visceral fat and total fat.Shares sank 49%, with intraday trading volume of over 40 million shares, against a daily average of about 3.3 million.Cibus  said Thursday it has priced an underwritten public offering of almost 7 million class A shares at $2.15 apiece. The stock closed at $2.87 in the previous day.Shares slid about 25% as intraday trading volume soared to over 1.66 million from a daily average of about 478,000.Price: 6.43, Change: -5.87, Percent Change: -47.72","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"WVE":"Wave Life Sciences Pte. Ltd","CBUS":"Cibus Inc","BK4139":"生物科技","BK4007":"制药"},"translate_title":"午盘跌幅最大的股票","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WVE":1,"CBUS":1},"content_text":"Wave Life Sciences (WVE) said Thursday phase 1 data showed a 240-milligram dose of its WVE-007 improved body composition, with clinically meaningful reductions in visceral fat and waist circumference, at a six-month follow-up.The company also reported data from participants in the 400 mg cohort, including visceral fat and total fat.Shares sank 49%, with intraday trading volume of over 40 million shares, against a daily average of about 3.3 million.Cibus (CBUS) said Thursday it has priced an underwritten public offering of almost 7 million class A shares at $2.15 apiece. The stock closed at $2.87 in the previous day.Shares slid about 25% as intraday trading volume soared to over 1.66 million from a daily average of about 478,000.Price: 6.43, Change: -5.87, Percent Change: -47.72","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622893585","isCrawlerRequest":true}